Source: BEFREE

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.070 Biomarker BEFREE Creatine transporter is currently the focus of renewed interest with emerging roles in brain neurotransmission and physiology, and the bioenergetics of cancer metastases. 29478817

2018
Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.070 Biomarker BEFREE Patients undergoing extended CRT were more likely to harbor larger initial tumor size (p = 0.04), baseline nodal metastases (cN+; p < 0.001) and higher tumor location (p = 0.02). 29217398

2018
Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.070 Biomarker BEFREE FDG accumulation in the caudate or left liver lobe after CRT in the area that received a high radiation dose may be caused by metastases or RILI. 29051991

2018
Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.070 Biomarker BEFREE Median time from CRT completion to disease recurrence or metastasis was 73 days (1-152). 30211118

2018
Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.070 Biomarker BEFREE Postoperative CT and CRT both were beneficial for patients with positive lymph nodes, particularly for those with 3 or more lymph nodes involvement and metastasis in the middle thoracic segment compared with surgery alone. 28819406

2017
Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.070 Biomarker BEFREE However, the precise mechanism of tumour metastasis regulated by CRT remains unclear. 24593306

2014
Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis 		0.070 Biomarker BEFREE ALNs were analyzed by routine pathology (hematoxylin-eosin staining), and by multimarker real-time reverse transcriptase-polymerase chain reaction analysis CRT-PCR to detect breast cancer metastases. 16213901

2005